Alcon Inc. (ALC)
| Market Cap | 34.64B -14.1% |
| Revenue (ttm) | 10.86B +8.3% |
| Net Income | 643.00M -40.1% |
| EPS | 1.31 -39.2% |
| Shares Out | 483.40M |
| PE Ratio | 53.88 |
| Forward PE | 17.69 |
| Dividend | $0.23 (0.32%) |
| Ex-Dividend Date | May 6, 2026 |
| Volume | 607,665 |
| Open | 71.89 |
| Previous Close | 72.01 |
| Day's Range | 71.39 - 72.45 |
| 52-Week Range | 61.84 - 87.64 |
| Beta | 0.69 |
| Analysts | Buy |
| Price Target | 85.24 (+17.77%) |
| Earnings Date | Aug 10, 2026 |
About ALC
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS... [Read more]
Financial Performance
In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.
Financial StatementsAnalyst Summary
According to 26 analysts, the average rating for ALC stock is "Buy." The 12-month stock price target is $85.24, which is an increase of 17.77% from the latest price.
News
Alcon Prices EUR 500 Million Senior Notes Offering
GENEVA--(BUSINESS WIRE)--Alcon Prices EUR 500 Million Senior Notes Offering.
Alcon (ALC) Q2 2026 Earnings Call Transcript
Net sales grew 7% to $2.8 billion as surgical and vision care divisions both expanded.
Alcon price target raised to CHF 73 from CHF 70 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Alcon (ALC) to CHF 73 from CHF 70 and keeps a Buy rating on the shares.
Alcon price target raised to $78.40 from $77.53 at JPMorgan
JPMorgan raised the firm’s price target on Alcon (ALC) to $78.40 from $77.53 and keeps a Neutral rating on the shares. The firm says the company is confident that its…
Alcon price target raised to $78.40 from $77.53 at JPMorgan
JPMorgan raised the firm’s price target on Alcon (ALC) to $78.40 from $77.53 and keeps a Neutral rating on the shares. The firm says the company is confident that its…
Alcon price target raised to $85 from $80 at Mizuho
Mizuho analyst Anthony Petrone raised the firm’s price target on Alcon (ALC) to $85 from $80 and keeps an Outperform rating on the shares post the Q2 report. The firm…
Alcon price target raised to CHF 63.50 from CHF 62.80 at JPMorgan
JPMorgan raised the firm’s price target on Alcon (ALC) to CHF 63.50 from CHF 62.80 and keeps a Neutral rating on the shares.
Alcon downgraded to Neutral from Outperform at BNP Paribas
BNP Paribas downgraded Alcon (ALC) to Neutral from Outperform with a $79 price target The firm sees a challenged outlook for the company in the second half of 2026 and…
Mining company rapidly acquiring village land, allege Surla locals
Surla village gram sabha in Goa saw heated debate over Alcon cement factory pollution, worker regularisation, and alleged large-scale land purchases by a mining company.
Bill Ackman Unveils Six New Investments In Major Portfolio Overhaul
WASHINGTON (dpa-AFX) - Billionaire investor Bill Ackman has added six new holdings to his investment portfolio, including Netflix, Visa, Mastercard, Alcon, Intercontinental Exchange and S&P Global...
Bill Ackman Moves Stocks. These 5 Prove It.
Netflix, Visa and other stocks rose on the news that Bill Ackman was investing in them. The billionaire focuses on buying what he views as high-quality growth companies.
Bill Ackman once exited Netflix stake in a huff. Why he's buying the streaming giant again as well as these five stocks.
Netflix is once again an apple in Bill Ackman's eye, as the streamer was among six stocks Pershing Square added in the last six months.
RxSight (RXST) Q2 2026 Earnings Call Transcript
Alcon partnership revenue offsets 19% product sales decline from competitive pressure.
Alcon Stock Jumps 4% as Tariff Relief Lifts Profit Target
Alcon Stock Jumps 4% as Tariff Relief Lifts Profit Target
Alcon Releases Q2 2026 Financial Results
Alcon Inc. The post Alcon Releases Q2 2026 Financial Results first appeared on Alphastreet .
Alcon Earnings Call Transcript: Q2 2026
Q2 2026 saw 7% sales growth, driven by strong adoption of UNITY equipment, PanOptix Pro IOL, and robust contact lens and ocular health performance. Core margins and EPS improved, with guidance reaffirmed for 5%-7% sales growth and 12%-15% EPS growth. Key launches and innovation are expected to sustain momentum.
Alcon Quarterly report: Q2 2026
Alcon has published its Q2 2026 quarterly earnings report on August 11, 2026.
Alcon Earnings release: Q2 2026
Alcon released its Q2 2026 earnings on August 11, 2026, summarizing the period's financial results.
Alcon Slides: Q2 2026
Alcon has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 11, 2026.
Eye care company Alcon raises profitability outlook, cuts tariff hit estimate
Swiss-American eye care company Alcon on Monday hiked its profit guidance and lowered its estimate for the full-year tariff impact to $40 million to $90 million, factoring in an anticipated refund ...
Alcon Q2 Core EPS Rises
(RTTNews) - Alcon Inc. (ALC) reported Tuesday that its second-quarter net income attributable to shareholders was nil, compared with $176 million, or $0.35 per share, in the year-ago quarter.
Alcon (ALC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street esti...
Alcon reports Q2 EPS 84c, consensus 76c
Reports Q2 revenue $2.78B, consensus $2.77B. “Our team delivered strong second-quarter results and executed well across the business,” said David J. Endicott, Alcon’s (ALC) Chief Executive Officer. “U...
Alcon raises FY26 EPS growth view to 12%-15% from 10%-13%
Consensus $3.47. Affirms FY26 revenue growth view of 5%-8%, consensus $11.13B. This outlook assumes the following: Aggregated markets grow approximately 3% to 4%. As of the end of July the…
Alcon up 5% above $77 after Q2 results, FY26 EPS guide raise
16:44 EDT Alcon (ALC) up 5% above $77 after Q2 results, FY26 EPS guide raise